tradingkey.logo
tradingkey.logo
検索

Boston Scientific Corp

BSX
ウォッチリストに追加
44.205USD
-0.255-0.57%
終値 06/25, 16:00ET15分遅れの株価
65.70B時価総額
18.39直近12ヶ月PER

詳細情報 Boston Scientific Corp 企業名

Boston Scientific Corporation is a global developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company's MedSurg segment includes Endoscopy, Urology, and Neuromodulation. Its Endoscopy business develops and manufactures devices to diagnose and treat a range of gastrointestinal conditions with less-invasive technologies. Its Urology business develops and manufactures devices to treat various urological conditions for both male and female anatomies, including kidney stones, benign prostatic hyperplasia, prostate cancer, erectile dysfunction, and incontinence. Its Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. Its Cardiovascular segment includes Cardiology and Peripheral Interventions. The Cardiology includes interventional cardiology therapies, watchman, cardiac rhythm management, and electrophysiology.

Boston Scientific Corpの企業情報

企業コードBSX
会社名Boston Scientific Corp
上場日May 19, 1992
最高経営責任者「CEO」Mahoney (Michael F)
従業員数53000
証券種類Ordinary Share
決算期末May 19
本社所在地300 Boston Scientific Way
都市MARLBOROUGH
証券取引所NASDAQ OMX NASDAQ Basic NYSE
United States of America
郵便番号01752-1234
電話番号15086834000
ウェブサイトhttps://www.bostonscientific.com/en-US/Home.html
企業コードBSX
上場日May 19, 1992
最高経営責任者「CEO」Mahoney (Michael F)

Boston Scientific Corpの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Michael F. (Mike) Mahoney
Mr. Michael F. (Mike) Mahoney
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
1.86M
+0.66%
Mr. John E. Sununu
Mr. John E. Sununu
Independent Director
Independent Director
54.72K
--
Mr. Vance R. Brown
Mr. Vance R. Brown
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
54.24K
--
Mr. David S. (Dave) Wichmann
Mr. David S. (Dave) Wichmann
Independent Director
Independent Director
45.38K
+8.37%
Mr. Jonathan R. Monson
Mr. Jonathan R. Monson
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
37.99K
--
Ms. Ellen M. Zane
Ms. Ellen M. Zane
Independent Director
Independent Director
27.93K
+13.60%
Mr. David C. Habiger
Mr. David C. Habiger
Independent Director
Independent Director
13.88K
+59.45%
Mr. Yoshiaki Fujimori
Mr. Yoshiaki Fujimori
Independent Director
Independent Director
2.08K
--
Mr. Joseph M. Fitzgerald
Mr. Joseph M. Fitzgerald
Executive Vice President, Group President - Cardiology
Executive Vice President, Group President - Cardiology
--
--
Mr. Edward J. Ludwig
Mr. Edward J. Ludwig
Lead Independent Director
Lead Independent Director
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Michael F. (Mike) Mahoney
Mr. Michael F. (Mike) Mahoney
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
1.86M
+0.66%
Mr. John E. Sununu
Mr. John E. Sununu
Independent Director
Independent Director
54.72K
--
Mr. Vance R. Brown
Mr. Vance R. Brown
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
54.24K
--
Mr. David S. (Dave) Wichmann
Mr. David S. (Dave) Wichmann
Independent Director
Independent Director
45.38K
+8.37%
Mr. Jonathan R. Monson
Mr. Jonathan R. Monson
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
37.99K
--
Ms. Ellen M. Zane
Ms. Ellen M. Zane
Independent Director
Independent Director
27.93K
+13.60%

よくある質問

Boston Scientific Corpの上位5名の株主は誰ですか?

Boston Scientific Corpの上位5名の株主は以下のとおりです。Mr. Michael F. (Mike) Mahoney

Boston Scientific Corp(BSX)の株式を保有している機関の数はいくつですか?

2026Q1時点で、Boston Scientific Corpの株式を保有している機関は3113社あり、保有株式の総市場価値は約1.40Bで、全体の94.35%を占めています。2025Q4と比較して、機関の持ち株は-15512534.00増加しています。

Boston Scientific Corpの最大の収益源は何ですか?

2026Q1において、Interventional Cardiology Therapies部門がBoston Scientific Corpにとって最大の収益を生み出しており、その金額は4.64Bで、全収益の23.11%を占めています。
KeyAI